With four newly available IVDR-certified CytoCell FISH probes designed to detect clinically relevant variants associated with haematological malignancies, including chron...
Read articleWith four newly available IVDR-certified CytoCell FISH probes designed to detect clinically relevant variants associated with haematological malignancies, including chronic lymphocytic leukaemia and multiple myeloma
ReadNew RNA-based NGS panel helps to detect, analyse and track high-impact AML-associated fusion events across multiple timepoints
ReadDelivering reduced hands-on time, more consistent results and higher sample throughput
ReadHelping high-throughput laboratories increase multiplexing capacity and maximise sequencing throughput without changing established workflows
ReadTransition programme begins with two IVDR-certified CytoCell® prenatal FISH probe kits designed to support rapid, standardised prenatal workflows.
ReadEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs.
ReadOGT’s CytoCell KMT2A Breakapart FISH Probe Kit PDx detects clinically relevant rearrangements that occur in patients with acute leukaemia, providing a robust, accessible, rapid turnaround test for KMT2Ar detection.
ReadThrough this partnership, SureSeq™ NGS panel users can gain access to streamlined, high-confidence genomic insights and efficient, scalable reporting from sample to result.
ReadOGT will be moving from plastic packaging to new, sustainable packaging for CytoCell products, an important step forward in our ongoing environmental efforts.
ReadImproving upon existing SureSeq™ technology, this latest SureSeq NGS panel unlocks more efficient and expansive genetic profiling for CLL samples
ReadEnables users to replace multiple techniques with a single streamlined NGS process for faster results.
ReadInvestment in new premises to create increase in cutting-edge genomic solutions and collaborative partnerships.
Read
Visit USA site
Visit Canada site
